Clinical Trials · NCT02262936

Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older

TerminatedPhase 2/Phase 3Desmopressin (Prohibited)
Phase
Phase 2/Phase 3
Recruitment status
Terminated
Sponsor
Mount Sinai Hospital, Canada
Enrollment
4
Start date
Jul 2015
Locations
1 site, Canada
Primary endpoint
Number of night time voids
View Desmopressin compound reference